An engineered β-galactosidase with improved stability and cross-correction for the potential treatment of GM1 Gangliosidosis via AAV gene therapy
In: Molecular Genetics and Metabolism, Jg. 138 (2023), Heft 2, S. 107285
academicJournal
Zugriff:
Titel: |
An engineered β-galactosidase with improved stability and cross-correction for the potential treatment of GM1 Gangliosidosis via AAV gene therapy
|
---|---|
Autor/in / Beteiligte Person: | Reddy, Charu ; Onguka, Ouma ; Artz, Jacob ; Schmitt, Christopher ; Grossman, Adam ; Santosh, Swetha ; Akinkugbe, Oluwayomi ; Wong, Victoria ; Gebretsadik, Kahsay ; Sedighi, Faezeh ; Tang, Jinyan ; Del Greco, Elizabeth ; Lee, Grace S. ; Kruse, Nikki ; Chng, Chinping ; Duan, Da ; Hallows, William C. ; Chen, Joseph C. ; Akeefe, Hassibullah ; Silverman, Adam P. ; Huisman, Gjalt |
Link: | |
Zeitschrift: | Molecular Genetics and Metabolism, Jg. 138 (2023), Heft 2, S. 107285 |
Veröffentlichung: | Elsevier BV, 2023 |
Medientyp: | academicJournal |
ISSN: | 1096-7192 |
DOI: | 10.1016/j.ymgme.2022.107285 |
Schlagwort: |
|
Sonstiges: |
|